ENX-102

ENX-102, also known as TPA-023B, is a GABA A receptor positive allosteric modulator, nonbenzodiazepine, and investigational anxiolytic which is under development for the treatment of generalized anxiety disorder and social phobia (social…

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

ENX-102, also known as TPA-023B, is a GABA A receptor positive allosteric modulator, nonbenzodiazepine, and investigational anxiolytic which is under development for the treatment of generalized anxiety disorder and social phobia (social anxiety disorder). It is taken orally.

The drug is a selective and partial positive allosteric modulator of α 2 , α 3 , and α 5 subunit-containing GABA A receptors, whereas it shows no activity at α 1 subunit-containing GABA A receptors, and is potentially "anxioselective", producing anxiolytic effects with little or no sedation, in contrast to existing agents like benzodiazepines and Z-drugs.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1371055346 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.